Categories
Weight Loss Exercise

Interesting Statistics About Smoking


Statistics about smoking are frightening. In this article we will look at figures produced by the US government and the World Health Organization. Some of the facts that you will see on this page will probably astonish you.

Statistics About Smoking In The USA

In the USA, more than 20% of all deaths are smoking-related. Around 20% of American adults now smoke (21.5% of men and 17.5% of women), and of course some smokers die from other causes, so it is clear that smoking can still contribute to serious diseases even after a smoker quits. This is not a reason not to quit, however – the sooner you quit, the less likely it is that you will die of a smoking-related disease.

Smoking in the USA is on the decrease. The number of American smokers is now less than half what it was 50 years ago. Nevertheless, smoking rates in some ethnic and social groups are still very high. Over 30% of adults who identify as Native American smoke, for example. People without a college degree are much more likely to be smokers than college graduates.

Smoking in the USA is more common in some states than others. Perhaps it is not surprising that Virginia, with its tobacco-growing economy, has the highest prevalence with almost 27% of adult residents being smokers. Smoking rates are generally higher in the Midwest and Southeast than in the Western and Northeastern states. The lowest proportion of smokers is found in Utah with just 9%.

Statistics About Smoking Worldwide

Statistics About Smoking

Statistics About Smoking

While the number of smokers is falling in developed countries like the USA, Western Europe and Australia, it is still rising in many other parts of the world. Around 33% of the adult male world population smokes, and around 20% of young people aged 13-15 smoke worldwide.

The proportion of smokers is highest in the WHO’s East Asia and Pacific region, with almost 66% of adult males being current smokers.

In a survey in China, it was found that over half of the adult population still does not know that smoking causes lung cancer. 96% of people there did not know that smoking causes heart disease. Even in the UK, where smoking rates are much lower and you might expect the population to be better informed, 98% of women did not know that smoking has been found to contribute to cancer of the cervix (the neck of the womb).

On average, every cigarette smoked reduces a person’s life expectancy by 5 minutes. It also takes around 5 minutes to smoke a cigarette. So you might say that a smoker loses 10 minutes of useful life every time that they light up.

Nicotine is not the only factor in smoking-related diseases. More than 4000 different toxins or carcinogenic (cancer-causing) substances have been found in cigarette smoke.

Around 50% of people who smoke for 15 years or more will die of the effects of smoking.

These are just a few of the statistics about smoking that have been discovered by national and worldwide surveys.

quit smoking today
Imagine if you could easily use the same method that allowed Paul Peyton, a heavy smoker for more than 14 years, ? to permanently quit overnight… Wouldn’t that be wonderful?

Well, guess what – you can. In fact, ANYONE can do it.

But first, you need to understand where you’ve gone wrong in the past… Treating just the physical addiction to smoking. But it can only be removed completely by using targeted psychotherapeutic techniques. NOT by ignoring it and hoping it will go away. And CERTAINLY NOT by throwing even more nicotine at it, in the form of patches or gum. You MUST deal with BOTH parts of your addiction the right way, or you will keep getting those cravings forever…

Specific, step by step instructions ? we show you exactly what to do, so nothing is left to chance. You choose the timeframe ? implement the method at your own pace, as you feel comfortable. Tried and tested method ? this cutting-edge method has been successfully used to cure thousands of happy ex-smokers. Permanently removes your mental dependence at the subconscious level ? resulting in a permanent end to mental cravings.

Check out PermaQuit now.

Sources for these statistics about smoking:

Fact Sheet on Smoking and Tobacco Use from the Centers for Disease Control and Prevention, Atlanta, GA.

WHO fact sheet on smoking statistics reported at about.com.


Related Blogs

  • Related Blogs on Adult Males
  • Related Blogs on Adult Population
Categories
Weight Loss Exercise

Using Copper to Cut Down on Hospital Infections?



Early results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms resulted in a 97 percent reduction of bacteria that cause hospital acquired infections.  This particular study also found a 40 percent reduction in the risk of acquiring an infection. Study results are to be submitted to the U.S. Environmental Protection Agency for review and approval.

Antimicrobial Copper Study

Using Copper to Cut Down on Hospital Infections?

Antimicrobial Copper Study

Initial study results were presented at the World Health Organization’s 1st International Conference on Prevention and Infection Control (ICPIC) in Geneva, Switzerland on July 1, 2011.

The study, funded by the U.S. Department of Defense, was designed to determine the efficacy of antimicrobial copper in reducing the level of pathogens in hospital rooms, and whether such a reduction would translate into a lower risk of infection.

Researchers at the three hospitals involved in the trial, Memorial Sloan Kettering Cancer Center in New York, the Medical University of South Carolina, and the Ralph H. Johnson VA Medical Center, both in Charleston, replaced commonly touched items, such as bed rails, overbed tray tables, nurse call buttons and IV poles, with antimicrobial copper versions.

Results of  Antimicrobial Copper Study

The reduction rate demonstrated on antimicrobial copper surfaces is the same as that achieved by “terminal” cleaning, the regimen conducted after each patient vacates a room.

Dr. Michael Schmidt, Professor and Vice Chairman of Microbiology and Immunology at MUSC, who presented the results at ICPIC, said, “Bacteria present on ICU room surfaces are probably responsible for up to 80 percent of patient infections, demonstrating how critical it is to keep hospitals clean. The copper objects used in the clinical trial lowered microbial levels and supplemented cleaning protocols.”

Hospital patients have a 1:20 chance of developing an infection, and those who do have a 1:20 chance of dying as a result. The CDC estimates that in the U.S., hospital acquired infections kill 100,000 people and cost $45 billion annually.

Independent laboratory testing has demonstrated that when cleaned regularly, antimicrobial copper products kill greater than 99.9% of the following bacteria within two hours of exposure:  MRSA, VRE, Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, and E. coli O157:H7.  For a complete listing of approved EPA public health claims for antimicrobial copper, please visit www.antimicrobialcopper.com. Clinical trial results are preliminary and under review; claims related to clinical trials have not been approved or reviewed by the U.S. EPA. Because many factors contribute to the risk of infection, individual results may vary.

Related Blogs

  • Related Blogs on Copper Surfaces
Categories
Weight Loss Exercise

Using Copper to Cut Down on Hospital Infections? | Antimicrobial Copper Study



Early results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms resulted in a 97 percent reduction of bacteria that cause hospital acquired infections.  This particular study also found a 40 percent reduction in the risk of acquiring an infection. Study results are to be submitted to the U.S. Environmental Protection Agency for review and approval.

Antimicrobial Copper Study

Using Copper to Cut Down on Hospital Infections?

Antimicrobial Copper Study

Initial study results were presented at the World Health Organization’s 1st International Conference on Prevention and Infection Control (ICPIC) in Geneva, Switzerland on July 1, 2011.

The study, funded by the U.S. Department of Defense, was designed to determine the efficacy of antimicrobial copper in reducing the level of pathogens in hospital rooms, and whether such a reduction would translate into a lower risk of infection.

Researchers at the three hospitals involved in the trial, Memorial Sloan Kettering Cancer Center in New York, the Medical University of South Carolina, and the Ralph H. Johnson VA Medical Center, both in Charleston, replaced commonly touched items, such as bed rails, overbed tray tables, nurse call buttons and IV poles, with antimicrobial copper versions.

Results of  Antimicrobial Copper Study

The reduction rate demonstrated on antimicrobial copper surfaces is the same as that achieved by “terminal” cleaning, the regimen conducted after each patient vacates a room.

Dr. Michael Schmidt, Professor and Vice Chairman of Microbiology and Immunology at MUSC, who presented the results at ICPIC, said, “Bacteria present on ICU room surfaces are probably responsible for up to 80 percent of patient infections, demonstrating how critical it is to keep hospitals clean. The copper objects used in the clinical trial lowered microbial levels and supplemented cleaning protocols.”

Hospital patients have a 1:20 chance of developing an infection, and those who do have a 1:20 chance of dying as a result. The CDC estimates that in the U.S., hospital acquired infections kill 100,000 people and cost $45 billion annually.

Independent laboratory testing has demonstrated that when cleaned regularly, antimicrobial copper products kill greater than 99.9% of the following bacteria within two hours of exposure:  MRSA, VRE, Staphylococcus aureus, Enterobacter aerogenes, Pseudomonas aeruginosa, and E. coli O157:H7.  For a complete listing of approved EPA public health claims for antimicrobial copper, please visit www.antimicrobialcopper.com. Clinical trial results are preliminary and under review; claims related to clinical trials have not been approved or reviewed by the U.S. EPA. Because many factors contribute to the risk of infection, individual results may vary.